BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 26700655)

  • 1. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis.
    Wallis CJD; Saskin R; Choo R; Herschorn S; Kodama RT; Satkunasivam R; Shah PS; Danjoux C; Nam RK
    Eur Urol; 2016 Jul; 70(1):21-30. PubMed ID: 26700655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy Strategies as Primary Treatment for High-risk Localized Prostate Cancer: A Systematic Review and Meta-analysis.
    Greenberger BA; Zaorsky NG; Den RB
    Eur Urol Focus; 2020 Mar; 6(2):404-418. PubMed ID: 31813810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
    Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
    Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose rate brachytherapy for men with localized prostate cancer.
    Peinemann F; Grouven U; Hemkens LG; Bartel C; Borchers H; Pinkawa M; Heidenreich A; Sauerland S
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008871. PubMed ID: 21735436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era.
    Kibel AS; Ciezki JP; Klein EA; Reddy CA; Lubahn JD; Haslag-Minoff J; Deasy JO; Michalski JM; Kallogjeri D; Piccirillo JF; Rabah DM; Yu C; Kattan MW; Stephenson AJ
    J Urol; 2012 Apr; 187(4):1259-65. PubMed ID: 22335870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the comparative effectiveness of radical prostatectomy, radiation therapy, or expectant management of localized prostate cancer in registry data.
    Serrell EC; Pitts D; Hayn M; Beaule L; Hansen MH; Sammon JD
    Urol Oncol; 2018 Apr; 36(4):183-192. PubMed ID: 29122446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study.
    Suárez JF; Zamora V; Garin O; Gutiérrez C; Pont À; Pardo Y; Goñi A; Mariño A; Hervás A; Herruzo I; Cabrera P; Sancho G; Ponce de León J; Macías V; Guedea F; Vigués F; Castells M; Ferrer M;
    Sci Rep; 2022 Jul; 12(1):12589. PubMed ID: 35869124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy: A Systematic Review and Meta-analysis.
    Foerster B; Pozo C; Abufaraj M; Mari A; Kimura S; D'Andrea D; John H; Shariat SF
    JAMA Oncol; 2018 Jul; 4(7):953-961. PubMed ID: 29800115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.
    van Tol-Geerdink JJ; Willem Leer J; Weijerman PC; van Oort IM; Vergunst H; van Lin EN; Alfred Witjes J; Stalmeier PF
    BJU Int; 2013 Apr; 111(4):564-73. PubMed ID: 22882966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of randomized trials in localized prostate cancer.
    Alibhai SM; Klotz LH
    Can J Urol; 2004 Feb; 11(1):2110-7. PubMed ID: 15003149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated evidence on oncological outcomes of surgery versus external beam radiotherapy for localized prostate cancer.
    Taguchi S; Shiraishi K; Fukuhara H
    Jpn J Clin Oncol; 2020 Sep; 50(9):963-969. PubMed ID: 32580211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis.
    Wallis CJ; Mahar AL; Choo R; Herschorn S; Kodama RT; Shah PS; Danjoux C; Narod SA; Nam RK
    BMJ; 2016 Mar; 352():i851. PubMed ID: 26936410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachytherapy versus external beam radiotherapy boost for prostate cancer: Systematic review with meta-analysis of randomized trials.
    Kee DLC; Gal J; Falk AT; Schiappa R; Chand ME; Gautier M; Doyen J; Hannoun-Levi JM
    Cancer Treat Rev; 2018 Nov; 70():265-271. PubMed ID: 30326422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review.
    Wallis CJD; Glaser A; Hu JC; Huland H; Lawrentschuk N; Moon D; Murphy DG; Nguyen PL; Resnick MJ; Nam RK
    Eur Urol; 2018 Jan; 73(1):11-20. PubMed ID: 28610779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
    Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
    J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
    Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.